OBJECTIVE: Notch is known as a transmembranous receptor family with four homologous forms - Notch 1, Notch 2, Notch 3, and Notch 4 and related to cell fate regulation and angiogenesis. The purpose is to investigate the effect of follicular stimulating hormone (FSH) on the Notch 1 expression and proliferation in ovarian cancer cells. METHODS: Human ovarian cancer cell line, SK-OV-3 and FSH were used. XTT cell proliferation and cell migration assay were carried out with FSH 100 mIU/mL and Notch 1 siRNA. Western blots and reverse transcriptase-polymerase chain reactions (RT-PCR) were carried out to determine the expression level of the Notch 1 protein and mRNA with FSH treatment in 0, 1, 5, 10, 100, 200, 300 mIU/mL concentrations. Immunofluorescent (IF) stains were performed in SK-OV-3 cell cultures with FSH 100 mIU/mL. Student-t tests were used in statistical analyses. RESULTS: The SK-OV-3 have Notch 1 receptors in their natural status. FSH stimulated SK-OV-3 cells in XTT cell proliferation and cell migration assays and notch 1 siRNA inhibited. The expression level of Notch 1 protein and mRNA were increased in a dose dependent pattern according to FSH concentrations compared to untreated cells. IF stains also showed brighter Notch1 expressions in the FSH treated cells compared to the control cells. CONCLUSION: FSH enhances proliferation & migration and Notch 1 signaling in SK-OV-3 cells. The Notch signaling probably supports one of the cell proliferating mechanisms of FSH in ovarian cancer cells.
OBJECTIVE:Notch is known as a transmembranous receptor family with four homologous forms - Notch 1, Notch 2, Notch 3, and Notch 4 and related to cell fate regulation and angiogenesis. The purpose is to investigate the effect of follicular stimulating hormone (FSH) on the Notch 1 expression and proliferation in ovarian cancer cells. METHODS:Humanovarian cancer cell line, SK-OV-3 and FSH were used. XTT cell proliferation and cell migration assay were carried out with FSH 100 mIU/mL and Notch 1 siRNA. Western blots and reverse transcriptase-polymerase chain reactions (RT-PCR) were carried out to determine the expression level of the Notch 1 protein and mRNA with FSH treatment in 0, 1, 5, 10, 100, 200, 300 mIU/mL concentrations. Immunofluorescent (IF) stains were performed in SK-OV-3 cell cultures with FSH 100 mIU/mL. Student-t tests were used in statistical analyses. RESULTS: The SK-OV-3 have Notch 1 receptors in their natural status. FSH stimulated SK-OV-3 cells in XTT cell proliferation and cell migration assays and notch 1 siRNA inhibited. The expression level of Notch 1 protein and mRNA were increased in a dose dependent pattern according to FSH concentrations compared to untreated cells. IF stains also showed brighter Notch1 expressions in the FSH treated cells compared to the control cells. CONCLUSION: FSH enhances proliferation & migration and Notch 1 signaling in SK-OV-3 cells. The Notch signaling probably supports one of the cell proliferating mechanisms of FSH in ovarian cancer cells.
Entities:
Keywords:
Follicular stimulating hormone; Notch 1; Ovarian cancer
Authors: Farzad Esni; Bidyut Ghosh; Andrew V Biankin; John W Lin; Megan A Albert; Xiaobing Yu; Raymond J MacDonald; Curt I Civin; Francisco X Real; Michael A Pack; Douglas W Ball; Steven D Leach Journal: Development Date: 2004-07-27 Impact factor: 6.868
Authors: P Zagouras; S Stifani; C M Blaumueller; M L Carcangiu; S Artavanis-Tsakonas Journal: Proc Natl Acad Sci U S A Date: 1995-07-03 Impact factor: 11.205
Authors: N D Lawson; N Scheer; V N Pham; C H Kim; A B Chitnis; J A Campos-Ortega; B M Weinstein Journal: Development Date: 2001-10 Impact factor: 6.868
Authors: Marek Pawlikowski; Maria Jaranowska; Hanna Pisarek; Robert Kubiak; Julita Fuss-Chmielewska; Katarzyna Winczyk Journal: Arch Med Sci Date: 2015-12-11 Impact factor: 3.318
Authors: Julita Fuss-Chmielewska; Maria Jaranowska; Hanna Pisarek; Robert Kubiak; Katarzyna Winczyk; Marek Pawlikowski Journal: Thyroid Res Date: 2015-02-05
Authors: Jun Chul Park; In Bok Chang; Jun Hyong Ahn; Ji Hee Kim; Joon Ho Song; Seung Myung Moon; Young-Han Park Journal: J Korean Neurosurg Soc Date: 2018-07-01